Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: A state of the art review

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Lawn, Stephen D ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Asymptomatic; Culture; Diagnosis; HIV; Screening; Subclinical; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; BACTERIUM LIPOPOLYSACCHARIDE; LIPOARABINOMANNAN; MYCOBACTERIUM ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN DETECTION; BACTERIAL CELL WALL; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HIGH RISK POPULATION; HIV ASSOCIATED TUBERCULOSIS; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LABORATORY TEST; LIPOARABINOMANNAN URINE LEVEL; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POINT OF CARE TESTING; PROTEINURIA; PUBLIC HEALTH SERVICE; REVIEW; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; SPUTUM SMEAR; TUBERCULOSIS; URINALYSIS; URINE LEVEL;

ANTIGENS, BACTERIAL; BACTERIOLOGICAL TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HUMANS; IMMUNOCHROMATOGRAPHY; LIPOPOLYSACCHARIDES; MYCOBACTERIUM TUBERCULOSIS; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; URINE;

EID: 84862189810     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-103     Document Type: Review

References (47)

1. Lawn SD, Zumla AI. Tuberculosis. Lancet 2011, 378:57-72. 10.1016/S0140-6736(10)62173-3, 21420161.
2. World Health Organization Global tuberculosis control 2011. Accessed on 21.12.11 at: http://www.who.int/tb/publications/global_report/en/index.html. World Health Organization.
3. Lawn SD, Churchyard G. Epidemiology of HIV-associated tuberculosis. Curr Opin HIV AIDS 2009, 4:325-333. 10.1097/COH.0b013e32832c7d61, 19532072.
4. Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 2009, 9:173-184. 10.1016/S1473-3099(09)70043-X, 19246021.
5. Lawn SD, Wood R. Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 2011, 204(Suppl 4):S1159-S1167. 10.1093/infdis/jir411, 3192543, 21996698.
6. McNerney R, Daley P. Towards a point-of-care test for active tuberculosis: obstacles and opportunities. Nat Rev Microbiol 2011, 9:204-213. 10.1038/nrmicro2521, 21326275.
7. Kashino SS, Pollock N, Napolitano DR, Rodrigues V, Campos-Neto A. Identification and characterization of Mycobacterium tuberculosis antigens in urine of patients with active pulmonary tuberculosis: an innovative and alternative approach of antigen discovery of useful microbial molecules. Clin Exp Immunol 2008, 153:56-62. 10.1111/j.1365-2249.2008.03672.x, 2432097, 18460016.
8. Choudhry V, Saxena RK. Detection of Mycobacterium tuberculosis antigens in urinary proteins of tuberculosis patients. Eur J Clin Microbiol Infect Dis 2002, 21:1-5. 10.1007/s10096-001-0651-7, 11913494.
9. Achkar JM, Lawn SD, Moosa MY, Wright CA, Kasprowicz VO. Adjunctive Tests for Diagnosis of Tuberculosis: Serology, ELISPOT for Site-Specific Lymphocytes, Urinary Lipoarabinomannan, String Test, and Fine Needle Aspiration. J Infect Dis 2011, 204(Suppl 4):S1130-S1141. 10.1093/infdis/jir450, 21996695.
10. Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J 2011, 38:1398-1405. 10.1183/09031936.00025711, 21700601.
11. Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, Dheda K. Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med 2010, 16:262-270. 10.1097/MCP.0b013e328337f23a, 20375787.
12. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012, 12:201-209. 10.1016/S1473-3099(11)70251-1, 3315025, 22015305.
13. Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, Kraus S, Binder A, Meldau R, Hardy A, Dheda K. Diagnostic accuracy of a urine LAM strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J 2012,
14. Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 2004, 53:391-403. 10.1111/j.1365-2958.2004.04183.x, 15228522.
15. Brennan PJ. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2003, 83:91-97.
16. Hunter SW, Gaylord H, Brennan PJ. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J Biol Chem 1986, 261:12345-12351.
17. Strohmeier GR, Fenton MJ. Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microbes Infect 1999, 1:709-717. 10.1016/S1286-4579(99)80072-0, 10611748.
18. Venisse A. Berjeaud JM, Chaurand P, Gilleron M. Puzo G: Structural features of lipoarabinomannan from Mycobacterium bovis BCG. Determination of molecular mass by laser desorption mass spectrometry. J Biol Chem 1993, 268:12401-12411.
19. Sada E, Aguilar D, Torres M, Herrera T. Detection of lipoarabinomannan as a diagnostic test for tuberculosis. J Clin Microbiol 1992, 30:2415-2418. 265515, 1401008.
20. Shah M, Martinson NA, Chaisson RE, Martin DJ, Variava E, Dorman SE. Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. J Clin Microbiol 2010, 48:2972-2974. 10.1128/JCM.00363-10, 2916614, 20534796.
21. Hall CL, Hardwicke J. Low molecular weight proteinuria. Annu Rev Med 1979, 30:199-211. 10.1146/annurev.me.30.020179.001215, 95574.
22. Tessema TA, Bjune G, Hamasur B, Svenson S, Syre H, Bjorvatn B. Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary anti-lipoarabinomannan detection in pulmonary tuberculosis. Scand J Infect Dis 2002, 34:97-103. 10.1080/00365540110077263, 11928861.
23. Reither K, Saathoff E, Jung J, Minja LT, Kroidl I, Saad E, Huggett JF, Ntinginya EN, Maganga L, Maboko L, et al. Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis. BMC Infect Dis 2009, 9:141. 10.1186/1471-2334-9-141, 2741465, 19715562.
24. Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, Brunet L, van Zyl SR, Peter J, Green C, et al. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 2010, 5:e9848. 10.1371/journal.pone.0009848, 2844421, 20352098.
25. Wood R, Racow K, Bekker LG, Middelkoop K, Vogt M, Kreiswirth BN, Lawn SD. Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria. BMC Infect Dis 2012, 12:47. 10.1186/1471-2334-12-47, 3349560, 22369353.
26. Lawn SD, Kerkhoff AD, Vogt M, Ghebrekristos Y, Whitelaw A, Wood R. Characteristics and Early Outcomes of Patients With Xpert MTB/RIF-Negative Pulmonary Tuberculosis Diagnosed During Screening Before Antiretroviral Therapy. Clin Infect Dis 2012, 54:1071-1079. 10.1093/cid/cir1039, 3309885, 22318975.
27. Pereira Arias-Bouda LM, Nguyen LN, Ho LM, Kuijper S, Jansen HM, Kolk AH. Development of antigen detection assay for diagnosis of tuberculosis using sputum samples. J Clin Microbiol 2000, 38:2278-2283. 86781, 10834989.
28. Hamasur B, Bruchfeld J, Haile M, Pawlowski A, Bjorvatn B, Kallenius G, Svenson SB. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J Microbiol Methods 2001, 45:41-52. 10.1016/S0167-7012(01)00239-1, 11295196.
29. Tessema TA, Hamasur B, Bjun G, Svenson S, Bjorvatn B. Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre. Scand J Infect Dis 2001, 33:279-284. 10.1080/003655401300077306, 11345220.
30. Boehme C, Molokova E, Minja F, Geis S, Loscher T, Maboko L, Koulchin V, Hoelscher M. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 2005, 99:893-900. 10.1016/j.trstmh.2005.04.014, 16139316.
31. Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker LG, Wood R. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 2009, 23:1875-1880. 10.1097/QAD.0b013e32832e05c8, 20108382.
32. Mutetwa R, Boehme C, Dimairo M, Bandason T, Munyati SS, Mangwanya D, Mungofa S, Butterworth AE, Mason PR, Corbett EL. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int J Tuberc Lung Dis 2009, 13:1253-1259. 3373957, 19793430.
33. Daley P, Michael JS, Hmar P, Latha A, Chordia P, Mathai D, John KR, Pai M. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int J Tuberc Lung Dis 2009, 13:989-995. 2951988, 19723379.
34. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, et al. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. J Acquir Immune Defic Syndr 2009, 52:145-151. 10.1097/QAI.0b013e3181b98430, 2815254, 19692904.
35. Gounder CR, Kufa T, Wada NI, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, Grant A, Dorman S, Chaisson RE, et al. Diagnostic Accuracy of a Urine Lipoarabinomannan Enzyme-Linked Immunosorbent Assay for Screening Ambulatory HIV-Infected Persons for TB. Future Microbiol 2011, 6:1067-1082. 10.2217/fmb.11.84, 3252681, 21958145.
36. Lawn SD, Nicol MP. Xpert(R) MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 2011, 6:1067-1082. 10.2217/fmb.11.84, 3252681, 21958145.
37. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, et al. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N Engl J Med 2010, 363:1005-1015. 10.1056/NEJMoa0907847, 2947799, 20825313.
38. Dawson R, Masuka P, Edwards DJ, Bateman ED, Bekker LG, Wood R, Lawn SD. Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis 2010, 14:52-58.
39. Lawn SD, Kerkhoff AD, Wood R. Location of Xpert MTB/RIF in centralised laboratories in South Africa undermines potential impact. Int J Tuberc Lung Dis 2012. 16:s701.
40. Lawn SD, Harries AD, Wood R. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS 2010, 5:18-26. 10.1097/COH.0b013e328333850f, 20046144.
41. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008, 22:1897-1908. 10.1097/QAD.0b013e32830007cd, 18784453.
42. Lawn SD, Ayles H, Egwaga S, Williams B, Mukadi YD. Santos Filho ED, Godfrey-Faussett P, Granich RM, Harries AD: Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. Int J Tuberc Lung Dis 2011, 15:287-295.
43. Monkongdee P, McCarthy KD, Cain KP, Tasaneeyapan T, Nguyen HD, Nguyen TN, Nguyen TB, Teeratakulpisarn N, Udomsantisuk N, Heilig C, et al. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med 2009, 180:903-908. 10.1164/rccm.200905-0692OC, 19628775.
44. Lawn SD, Kerkhoff AD, Pahlana P, Vogt M, Wood R. Incremental diagnostic yield of TB from sputum induction during screening of HIV patients before ART. Int J Tuberc Lung Dis 2012; in press.
45. Hillemann D, Rusch-Gerdes S, Boehme C, Richter E. Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System. J Clin Microbiol 2011, 49:1202-1205. 10.1128/JCM.02268-10, 3122824, 21270230.
46. Ligthelm LJ, Nicol MP, Hoek KG, Jacobson R, van Helden PD, Marais BJ, Warren RM, Wright CA. Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens. J Clin Microbiol 2011, 49:3967-3970. 10.1128/JCM.01310-11, 3209093, 21880965.
47. Kadival GV, Mazarelo TB, Chaparas SD. Sensitivity and specificity of enzyme-linked immunosorbent assay in the detection of antigen in tuberculous meningitis cerebrospinal fluids. J Clin Microbiol 1986, 23:901-904. 268746, 3086370.